Association of metabolic syndrome and chronic kidney disease with atrial fibrillation: A nationwide population-based study in Korea
Atrial fibrillation (AF) is the most common cardiac arrhythmia observed in clinical practice, and its incidence and prevalence have been progressively increasing with a rise in the aging population and lifestyle changes [1,2]. AF not only affects a patient ’s quality of life due to distressing symptoms but also leads to serious long-term consequences such as stroke and heart failure [3]. The pathophysiology underlying the onset and progression of AF is a complex process that remains unclear despite thorough investigation over the past 3 decades.
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Won-Seok Choe, Eue-Keun Choi, Kyung-Do Han, Eui-Jae Lee, So-Ryoung Lee, Myung-Jin Cha, Seil Oh Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Cardiac Arrhythmia | Cardiology | Chronic Kidney Disease | Diabetes | Endocrinology | Heart | Heart Failure | Metabolic Syndrome | Stroke | Study | Urology & Nephrology